Cargando…

Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma

TP53 mutation (TP53(mut)) occurs in 10–20% of diffuse large B-cell lymphoma (DLBCL) cases and serves as an unfavorable biomarker of DLBCL progression. It confers resistance to immunochemotherapy, high-dose chemotherapy, autologous stem cell transplantation, and anti-CD19 chimeric antigen receptor T-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Ying, Zhang, Mu-Chen, He, Yang, Li, Chen, Fang, Hai, Xu, Peng-Peng, Cheng, Shu, Zhao, Yan, Feng, Yan, Liu, Qian, Wang, Li, Zhao, Wei-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556001/ https://www.ncbi.nlm.nih.gov/pubmed/37798292 http://dx.doi.org/10.1038/s41392-023-01626-x

Ejemplares similares

Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients
por: Qin, Yan, et al.
Publicado: (2020)

Epigenetic priming improves salvage chemotherapy in diffuse large B-cell lymphoma via endogenous retrovirus-induced cGAS-STING activation
por: Liu, Jun, et al.
Publicado: (2023)

Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma
por: Voropaeva, Elena N., et al.
Publicado: (2019)

Prognostic value of BCL2 and TP53 genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP
por: Qin, Yan, et al.
Publicado: (2022)

P1155: MORE PRECISE RISK STRATIFICATION FOR TP53 MUTANT DIFFUSE LARGE B CELL LYMPHOMA
por: Du, Kai-Xin, et al.
Publicado: (2023)

Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma
por: Ebid, Osama Abd El Hameed, et al.
Publicado: (2023)

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
por: Liu, Yalu, et al.
Publicado: (2017)

Influence of TP53 Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era
por: Porpaczy, Edit, et al.
Publicado: (2021)

PB2385: CINOBUFAGIN PROMOTES APOPTOSIS OF DIFFUSE LARGE B LYMPHOMA CELLS BY INHIBITING UBIQUITINATION DEGRADATION OF TP53
por: He, Sanxiu, et al.
Publicado: (2023)

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
por: Shen, Rong, et al.
Publicado: (2023)

Integrative genome‐wide chromatin accessibility and transcriptome profiling of diffuse large B‐cell lymphoma
por: Fang, Ying, et al.
Publicado: (2022)

Epigenetic interplay between mouse endogenous retroviruses and host genes
por: Rebollo, Rita, et al.
Publicado: (2012)

Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors
por: Cao, Yang, et al.
Publicado: (2016)

α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis
por: Cai, Yiqing, et al.
Publicado: (2023)

Human endogenous retroviruses in cancer: Expression, regulation and function
por: Gao, Yuan, et al.
Publicado: (2021)

Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
por: Tang, Jing, et al.
Publicado: (2023)

Expression and Regulation of the Endogenous Retrovirus 3 in Hodgkin’s Lymphoma Cells
por: Kewitz, Stefanie, et al.
Publicado: (2013)

Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma
por: Zhang, Mu-Chen, et al.
Publicado: (2020)

The discovery of endogenous retroviruses
por: Weiss, Robin A
Publicado: (2006)

Endogenous retroviruses in primates
por: Brown, Katherine, et al.
Publicado: (2011)

The KRAB zinc finger protein ZFP809 is required to initiate epigenetic silencing of endogenous retroviruses
por: Wolf, Gernot, et al.
Publicado: (2015)

P1220: EXPLORING TP53 BIOLOGY IN DIFFUSE LARGE B-CELL LYMPHOMA: A GENOMIC AND TRANSCRIPTOMIC META-ANALYSIS
por: Uppal, Manik, et al.
Publicado: (2023)

Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
por: Peng, Jianbo, et al.
Publicado: (2023)

JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide
por: Xu, Peng-Peng, et al.
Publicado: (2017)

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
por: Li, Xinyi, et al.
Publicado: (2023)

Locus specific human endogenous retroviruses reveal new lymphoma subtypes
por: Singh, Bhavya, et al.
Publicado: (2023)

Strain-Specific Epigenetic Regulation of Endogenous Retroviruses: The Role of Trans-Acting Modifiers
por: Elmer, Jessica L., et al.
Publicado: (2020)

Rewiring the transcriptional circuitries in cancer by endogenous retroviruses
por: Li, Li, et al.
Publicado: (2022)

A nomogram for predicting the rapid progression of diffuse large B‐cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 mutations
por: Liu, Cong, et al.
Publicado: (2023)

Development and validation of prognostic scoring in primary intestinal diffuse large B-cell lymphoma: a single-institution study of 184 patients
por: Fan, Xing, et al.
Publicado: (2021)

Endogenous retroviruses of non-avian/mammalian vertebrates illuminate diversity and deep history of retroviruses
por: Xu, Xiaoyu, et al.
Publicado: (2018)

Leukemic phase and CSF involvement of diffuse large B‐cell lymphoma with a complex karyotype including a TP53 deletion
por: Sinkoff, Jillian, et al.
Publicado: (2017)

Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome?
por: Asmar, Fazila, et al.
Publicado: (2014)

Transcription of human endogenous retroviruses in human brain by RNA-seq analysis
por: Li, Fang, et al.
Publicado: (2019)

Endogenous Retroviruses and Human Evolution
por: Khodosevich, Konstantin, et al.
Publicado: (2002)

Endogenous retroviruses of the chicken genome
por: Huda, Ahsan, et al.
Publicado: (2008)

Immunity to human endogenous retroviruses
por: Nixon, Douglas F
Publicado: (2011)

Paleovirology of human endogenous retroviruses
por: Gifford, Robert J, et al.
Publicado: (2009)

Endogenous Retroviruses in Domestic Animals
por: Garcia-Etxebarria, Koldo, et al.
Publicado: (2014)

On the concept and elucidation of endogenous retroviruses
por: Weiss, Robin A.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bt2klfgk548l5npd3en1brn473